Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population‐Based Registry
Fahad Almehmadi(University of Toronto), Kumaraswamy Nanthakumar(University Health Network), Douglas S. Lee(University of Toronto), Andreu Porta‐Sánchez(Hospital Clínic de Barcelona), Xuesong Wang(Jiangnan University), Andrew C.T. Ha(University Health Network), Hadas D. Fischer(Institute for Clinical Evaluative Sciences), Peter C. Austin(University of Toronto)
Cited by 35
Related Papers
Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring
|Circulation|2019|570
The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF
|JACC Heart Failure|2018|498
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction
|Canadian Journal of Cardiology|2021|290
Intensive Hemodialysis Associates with Improved Survival Compared with Conventional Hemodialysis
|Journal of the American Society of Nephrology|2012|217